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Objective. To compare scores for the Leeds enthesitis index in psoriatic arthritis and rheumatoid arthritis using clinical assessment
and ultrasonography (US). Design. Swelling and tenderness of the enthesis was assessed at six sites: lateral epicondyles of humerus
(LE), medial condyles of femur (MC), and the insertion of the Achilles tendon (AT). US assessed “inﬂammatory activity” (power
Doppler signal, oedema, tendon thickening, and bursal swelling) and “damage” (erosions and enthesophytes). Results.9 4p a t i e n t s
were included, 71 with PsA and 23 with RA. The patients with RA were signiﬁcantly older (PsA 47.6 years; RA 62.6 years; (mean
diﬀerence in ages =15.0 years, 95% CI 9.3–20.7 years)). US scores were higher in RA at the LE, signiﬁcantly so for the “damage”
scores. No diﬀerences between RA and PsA were seen at the other sites. As a result, the odds ratio for PsA, given an US score above
the median, was 0.41 (0.13–1.03). However, using the clinical score, the odds ratio for PsA was 2.16 (0.81–5.70). Conclusions.
Although clinical scores of enthesitis are greater in PsA compared to RA, US enthesitis scores did not distinguish between RA and
PsA. This may in part be due to more frequent juxta-articular involvement in RA and in part due to the older age of the subjects
with RA.
1.Introduction
It is recognised that certain clinical features help diﬀerentiate
PsA from rheumatoid and other forms of arthritis [1].
Included among these distinguishing clinical features is the
presence of enthesitis. Entheses, the point of attachment of
ligaments and tendons to bone, are widely distributed in
the body, but the major entheses of the lower limb around
the calcaneum provide the hallmark features of enthesitis in
PsA and other spondyloarthropathies and form part of the
newly developed CASPAR classiﬁcation criteria for psoriatic
arthritis [1, 2]. Enthesitis may underlie most of the changes
found in the spine in spondyloarthropathy, and it has even
been suggested that enthesitis is the primary pathological
lesion in the peripheral joints in PsA [3]. Further, enthesitis
has been proposed as an important domain of assessment,
and outcome, in PsA [4, 5].
If clinical enthesitis is a classiﬁcation criterion and hall-
mark feature of spondyloarthropathy, and if clinical enthesi-
t i si st ob em e a s u r e da sa ni n d i c a t o ro fd i s e a s ea c t i v i t y ,t h e n
it should be anticipated that both clinical and US enthesitis
shouldnotbeprominentinotherrheumaticdiseases, suchas
rheumatoid arthritis. Generally,thatisthecase [6].However,
there is also evidence that the “blind” assessment of both
radiographs and US images fails to distinguish between the
two diseases [7,8]. Recently,an enthesis index speciﬁc toPsA
has been developed. This index examines tenderness at six
sites: lateral epicondyles of the humerus, medial condyles of2 ISRN Rheumatology
the femur, and the insertion of the Achilles tendon [9]. The
current study examined clinical and US evidence of enthesis
at these six sites in both psoriatic arthritis and rheumatoid
arthritis.
2.Methods
T h i ss t u d yw a sc a r r i e do u ta t3c e n t r e s :B r a d f o r d ,U K ,
Bogota, Colombia, and Wellington, New Zealand. At each
centre full ethical committee approval was given for this
study and all patients gave their signed, informed consent
to take part. Subjects were seen in rheumatology outpatient
clinics and, after consent procedures, examined using a
standardclinicalprotocol.Patientswithaphysiciandiagnosis
of PsA and RA were included in an approximate ratio of
2:1 PsA:RA. The protocol gathered clinical information
sufﬁcient to assess the CASPAR criteria [2], an acute phase
marker and a swollen joint count. The protocol included
an assessment of the entheses of the Leeds Enthesitis Index
(LEI). These include bilaterally the lateral epicondyle of the
humerus at the common extensor origin, the medial condyle
of the femur, superior to the joint line, at the origin of the
medical collateral ligament, and the posterior prominence
of the calcaneum at the insertion of the Achilles tendon)—
pressure was exerted at the enthesis suﬃcient to blanch the
ﬁngernailoftheexaminer (approximately4Kg).Inaddition,
the examiner assessed the presence of soft-tissue swelling
at the enthesis. For each entheseal site, an assessment was
made of the adjacent joint in terms of tenderness and soft-
tissue swelling. Careful attention was devoted to try and
distinguish, swelling and tenderness separately at the joint
and the juxta-articular enthesis.
3.UltrasoundExamination
The following US protocol was applied. US was performed
byexperienced radiologists (CG,MC bothwith over10years
experience in musculoskeletal US) or rheumatologists (AH,
2 years experience in musculoskeletal US, and BR, over 3
yearsinmusculoskeletalUS).Thesonographerswereblinded
to the patient’s condition, and patients were asked not to
communicate with the radiologist during the procedure.
When possible the scans were performed on the same day
as the clinical examination. The scans were performed on
thefollowingmachines:Bradford,PhilipsHDI5000machine
using a 10–15MHz linear probe; Bogota, General Electric
Logic P-5 using a 10–13MHz linear probe; Wellington, GE
Healthcare Logiqe machine using a 5–13MHz linear probe.
The sonographic assessments were made at each of the Leeds
enthesis sites (lateral epicondyles of the humerus, medial
condyles of the femur, and Achilles tendon insertions). The
common extensor origin of the humerus was evaluated with
the patient seated, and the hand resting on the knee with the
elbow slightly ﬂexed and the wrist in gentle internal rotation.
The medial collateral ligament insertion into the femur was
examined with the patient supine and the knee extended.
The tendo-Achilles insertion was examined with the patient
prone, with the feet hanging over the edge of the couch with
the ankle in neutral position.
Grey scale imaging in the longitudinal and transverse
planes was used to assess the enthesis for the presence of
erosions, enthesophytes, bursitis, entheseal thickening, and
perientheseal soft tissue oedema. Care was taken to negate
the eﬀect of anisotropy, and lesions were only scored if seen
in both planes. Lesions were scored as present (score 1) or
absent (score 0). An erosion was deﬁned as a step-down cor-
ticalcontourdefectseenintwoplanesand measuring greater
than or equal to 2mm in diameter. An enthesophyte was
deﬁned as step-up bony prominence at the end of a normal
bonecontourandformingabonyspurseenwithinthetendi-
nous portion of the enthesis. Bursitis was taken to be present
if there was a localised, well-delineated hypoechoic area at
the site of an anatomical bursa which was compressible,
indicating that it was due to ﬂuid. Entheseal thickening was
scoredaspresentiftherewasadiscrepancyin thethicknessat
thecontralateralenthesisorifthenormallysmooth entheseal
contour appeared bulky. No attempt was made to measure
the thickness of the enthesis due to perceived diﬃculties in
standardising the measurement site. Perientheseal soft tissue
oedema was scored as present if there was compressible ﬂuid
within the soft tissues on the outer margin of the enthesis.
The assessment of entheseal vascularisation was performed
using power Doppler. Individual optimisation of Doppler
gain and gate for detecting low velocity ﬂow was done and
a speciﬁc preset of power Doppler settings was used for
each machine. All entheses were assessed for the presence of
neovascularity in the longitudinal and transverse plains just
adjacent to the entheseal insertion. Entheseal vascularity was
scored as present (score 1) or absent (score 0).
Interobserver agreement between centres was obtained
by agreeing deﬁnitions of lesions (as indicated above) and




All statistics were carried out using SPSS v15.0. The US
assessments were combined as follows, as an approximation
of “inﬂammation” and “damage” at the enthesis:
(i) the four items of vascularisation, soft-tissue oedema,
bursitis and thickening as an “inﬂammation” score
(score range 0–4),
(ii) the two items of erosion and enthesophyte as a
“damage” score (score range 0–2).
Aggregate LEI and US scores across all sites were used
to compare between disease categories. Sensitivity and
speciﬁcity of the LEI and US indices in PsA (using RA as a
comparator) were calculated by taking the median score of
each index in the PsA group as the cutoﬀ for positivity. In
this way it was also possible to calculate the odds ratios for
PsA, given a positive clinical or US score.ISRN Rheumatology 3
Table 1: “Inﬂammation”and“damage” scores by US at each enthe-
sis. Scores are mean (median and IQR).
Psoriaticarthritis Rheumatoid arthritis
Inﬂammation Damage Inﬂammation Damage
LER 1.0 (0,2) 0.5 (0,1) 1.4 (1,3) 1.0 (1,2)∗
LEL 0.7 (0,1.3) 0.4 (0,1) 1.0 (1,2) 0.8 (1,2)∗
MCR 1.4 (1,3) 0.5 (0,1) 1.3 (1,2) 0.7 (1,1)
MCL 1.7 (2,3) 0.7 (1,1) 1.6 (2,3) 0.8 (1,0.75)
ATR 0.9 (0,2) 0.6 (0,1) 0.9 (0,2) 0.4 (0,1)
ATL 1.0 (0,2) 0.5 (0,1) 0.6 (0,1) 0.3 (0,0.75)
∗Comparison of PsA and RA denotes P = .02 using Mann-Whitney U-test.
LER:right lateralepicondyle,LEL:leftlateralepicondyle,MCR:right medial
condyle,MCL:leftmedialcondyle,ATR:rightAchillestendoninsertion,and
ATL: left Achilles tendon insertion.
5.Results
The study included 94 patients, 71 with PsA (36 male, 35
female, mean age 47.6 years, mean duration of disease 5.5
years, mean CRP 15.7mg/dL, mean swollen joint count 2.5)
and 23 with RA (10 male, 13 female, mean age 62.6 years,
mean duration of disease 12.6 years, mean CRP 8.9mg/dL,
mean swollen joint count 3.9). The diﬀerence in age between
thetwogroupswassigniﬁcant (meandiﬀerencein ages=15.0
years, 95%CI 9.3–20.7 years).
USscoresweregenerallyhigherforRAattheepicondyles,
signiﬁcantly so for the “damage” scores (Table 1). The sen-
sitivity and speciﬁcity of the US scores for “diagnosing” PsA
(withRAasthecomparator)were 0.41and 0.37,respectively.
For the clinical score (the LEI) these ﬁgures were 0.54 and
0.65, respectively. The odds ratio (OR) for having PsA, given
an aggregate US score above the median was 0.41 (95% con-
ﬁdence intervals: 0.13–1.03), for the clinical score (LEI) and,
the OR was 2.16 (0.81–5.70).
Given that four of the LEI points are adjacent to joints,
the relationship between entheseal tenderness, USscores and
tenderness and swelling in the adjacent joint as examined
and the results given in Table 2. Only a few joints were
clinically swollen so only the results for articular tenderness
are presented, but the results for joint swelling were quali-
tatively similar. A signiﬁcant relationship between articular
tenderness and US scores was found for the right elbow and
right knee only. However, scores were generally higher when
the adjacent joint was tender, with the exception of the ankle
joints. There was proportionally more articular involvement
inthecaseswithRA,withoverallﬁguresforarticularswelling
andtendernessinRAof16%and18%,respectively;thesame
ﬁgures for PsA were 3% and 15%, respectively.
6.Discussion
This study was done as part of the ongoing validation of
the LEI. In particular the aim was to examine the speciﬁc-
ity of the instrument both based on clinical and US as-
sessment comparing two diﬀering types of rheumatic dis-
ease. Although clinical assessment appeared to conﬁrm the
speciﬁcity of the LEI, the results suggest that an US index,
Table 2: “Inﬂammation”and “damage” US scores for each enthesis
according to the presence or absence of juxta-articular jointtender-
ness. Scores are the mean (median, IQR).
Inﬂammationindex at
associated enthesis
Damage index at associated
enthesis
Tender Nontender Tender Nontender
EJR 1.9 (2,2.8) 0.8 (0,2.0)∗ 0.9 (1,2.0) 0.5 (0,1.0)∗
EJL 1.0 (1,2.0) 0.7 (0,1.3) 0.7 (1,1.0) 0.5 (0,1.0)
KJR 2.3 (3,2.5) 1.3 (1,2.0)∗ 0.8 (1,0.8) 0.5 (1,1.0)
KJL 1.5 (2,3.0) 1.7 (2,3.0) 0.7 (1,1.0) 0.8 (1,0.3)
AJR 1.0 (1,2.0) 0.8 (0,2.0) 0.4 (0,0.8) 0.5 (0,1.0)
AJL 1.0 (0,2.0) 0.8 (0,1.5) 0.5 (0,1.5) 0.4 (0,1.0)
∗Comparison of tender versus nontender: denotes P<. 05 using Mann-
Whitney U-test.
EJR: right elbow joint, EJL: left elbow joint, KJR: right knee joint, KJL: left
knee joint, AJR: right ankle joint, AJL: left ankle joint.
employing a recognised framework for recording both grey-
scale and power Doppler features of enthesitis, cannot read-
ily distinguish between rheumatoid arthritis and psoriatic
arthritis. Indeed, US scores were higher in RA compared to
PsA at the lateral epicondyles of the elbow. The discrepancy
between clinical and US enthesitis in spondyloarthropathy
is not a novel ﬁnding [10, 11]. This may in part be due
to the fact that clinical examination and US are measuring
diﬀerent things. For example, US cannot visualise osteitis
yet, osteitis may cause tenderness at the enthesis. Osteitis, or
bone oedema, can be visualised at the enthesis in spondy-
loarthropathy using MRI and this has been interpreted
as indicating enthesitis [12]. In this way, tenderness at the
enthesismayhaveadiﬀerentmeaningtoUSappearancesand
may in fact be a more sensitive sign of enthesitis, but further
studies are required to resolve this issue.
Previous studies comparing US enthesitis in spondyloar-
thropathy and “controls” have been conﬂicting. An Italian
group found abnormalities around the heel equally in PsA
and RA [8] but other studies, including one from the same
group, have not been able to conﬁrm this result [10, 13].
Certain entheseal sites have a closer relationship with joints
than others, this being one reason why the MASES index
favoured sites that were not adjacent to joints [14]. One
possible explanation for the results of the current study is
that articular inﬂammation, particularly at the elbowand ra-
diohumeral joint, may extend to the enthesis at the lateral
epicondyle. A similar argument could be used for the medial
condyle of the femur and the knee joint. However, this
argument could not apply to the ankle and the Achilles
tendon and the results from Table 2 would support this.
In this way, enthesitis and entheseal new bone forma-
tion may be seen in RA. However, studies using plain radi-
ographic images have indicated that entheseal new bone
formation may also occur at sites remote from joints, such
as the Achilles insertion and around the pelvic bones [7].
In the CASPAR study, a large international study to develop
new classiﬁcation criteria for psoriatic arthritis, images of
588patientswithpsoriatic arthritis werecomparedtoimages
from 395 patients with rheumatoid arthritis and 97 patients4 ISRN Rheumatology
with ankylosing spondylitis [7]. Entheses examined were at
the calcaneus, the knee and the pelvis. No diﬀerences in
entheseal new bone formation between psoriatic arthritis
and rheumatoid arthritis were found. A further consider-
ation of the results from Table 1 is the diﬀerence in the
average ages of the patients from the two groups. The
patients with rheumatoid arthritis were signiﬁcantly older
than the patients with PsA. Given that degenerative changes,
representedbyenthesophytes,inarticularandjuxta-articular
structures are likely to increase with age this may explain the
signiﬁcant diﬀerencesin Table 1. The higher “inﬂammation”
scores in rheumatoid arthritis would not be explained by
this mechanism, particularly since these were mainly seen
at the elbow. An argument could have been made for more
frequentinﬂammatory changes intheretrocalcaneal bursain
rheumatoid arthritis, yet this was not observed in this study.
Interobserver diﬀerences in the measurement of US
enthesitis have been previously noted. In this study a three-
step process to improve reliability of these features, as previ-
ously described by D’Agostino et al. [15], was not adopted.
Instead, we aimed to obtain some form of standardisation
by the use of a CD of standard images. However, given that
the main ﬁnding of this paper was the diﬀerence between
the two disease groups, PsA and RA, and that this contrast
was replicated across the centres, absolute agreement on the
presenceorabsence offeatures islessimportant: inthis sense
centres acted as their own controls.
The hypothesis that PsA is largely an entheseal-based
disease, and RA is one largely synovial based, is not
supported by this study [3]. However, it should be noted that
most of the cases in this study had established disease and
contiguous spread of inﬂammation might have obfuscated
the initial sites of inﬂammation. Such a mechanism might
haveexplainedtheﬁndings ofMarzo-Ortega etal.who could
not diﬀerentiate RA and PsA on the basis of MRI studies of
the hand in relatively early disease [16].
In summary, the results of this study suggest that US
evidence of enthesitis cannot distinguish between RA and
PsA, possibly because of the more frequent juxta-articular
inﬂammation in RA. Further studies are needed with alter-
native clinical ways of assessing enthesitis and using MRI
and US for imaging comparison.
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